COVID19 therapeutics: Expanding the antiviral arsenal
EBioMedicine
.
2021 Apr:66:103289.
doi: 10.1016/j.ebiom.2021.103289.
Epub 2021 Mar 19.
Author
Tom Gallagher
1
Affiliation
1
Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA. Electronic address: tgallag@luc.edu.
PMID:
33752131
PMCID:
PMC7977477
DOI:
10.1016/j.ebiom.2021.103289
No abstract available
Publication types
Comment
MeSH terms
Antiviral Agents / therapeutic use
COVID-19*
Humans
SARS-CoV-2
Substances
Antiviral Agents
Grants and funding
P01 AI060699/AI/NIAID NIH HHS/United States